diramCHK

Looking for the Biotech Breakout

Many biotech companies are indeed in the hedge of important technological breakthroughs but they have still a long way to go until they can show a marginal profit on the stock values.
One of these companies is the israeli-based D-Medical biomed firm (Nilimedics, G-Sense, SinDolor Medical) engaged among other products in a III-level program for a new insuline pump-type for diabetic users.
The company has already made important progress in the R&D and expect important developments. Worth to watch.